Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 90

1.

Has "levodopa-induced neuropathy" been reported in Parkinson's disease clinical trials?

Teodoro T, Pires D, Rosa MM, Coelho M, Sampaio C, Ferreira JJ.

Mov Disord. 2011 Aug 15;26(10):1966-7. doi: 10.1002/mds.23760. Epub 2011 May 12. No abstract available.

PMID:
21567458
[PubMed - indexed for MEDLINE]
2.

Reply: neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.

Toth C, Suchowersky O, Zochodne D.

Mov Disord. 2010 Mar 15;25(4):525. doi: 10.1002/mds.22879. No abstract available.

PMID:
20155864
[PubMed - indexed for MEDLINE]
3.

"Double crush" in Parkinson's disease.

Weinberger M, Inzelberg R.

Ann Neurol. 2010 Dec;68(6):972; author reply 973. doi: 10.1002/ana.22260. No abstract available.

PMID:
21194160
[PubMed - indexed for MEDLINE]
4.

Reversible encephalopathy and axonal neuropathy in Parkinson's disease during duodopa therapy.

Manca D, Cossu G, Murgia D, Molari A, Ferrigno P, Marcia E, Melis M.

Mov Disord. 2009 Nov 15;24(15):2293-4. doi: 10.1002/mds.22807. No abstract available.

PMID:
19795477
[PubMed - indexed for MEDLINE]
5.

[Clinical studies with levodopa/carbidopa intestinal gel].

Klivényi P, Vécsei L.

Ideggyogy Sz. 2014 Jan 30;67(1-2):5-8. Review. Hungarian.

PMID:
24654442
[PubMed - indexed for MEDLINE]
6.

Measuring motor complications in clinical trials for early Parkinson's disease.

Marras C, Lang AE.

J Neurol Neurosurg Psychiatry. 2003 Feb;74(2):143-6. Review. No abstract available.

PMID:
12531932
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

A case series of peripheral neuropathy in patients with Parkinson's disease.

Gondim Fde A, de Oliveira GR, Peixoto AA Jr, Horta WG.

Ann Neurol. 2010 Dec;68(6):973-5; author reply 975. doi: 10.1002/ana.22258. No abstract available.

PMID:
21194162
[PubMed - indexed for MEDLINE]
8.

Optimising levodopa therapy for the management of Parkinson's disease.

Stocchi F.

J Neurol. 2005 Oct;252 Suppl 4:IV43-IV48. Review.

PMID:
16222437
[PubMed - indexed for MEDLINE]
9.

Neuropathy and levodopa in Parkinson's disease: evidence from a multicenter study.

Ceravolo R, Cossu G, Bandettini di Poggio M, Santoro L, Barone P, Zibetti M, Frosini D, Nicoletti V, Manganelli F, Iodice R, Picillo M, Merola A, Lopiano L, Paribello A, Manca D, Melis M, Marchese R, Borelli P, Mereu A, Contu P, Abbruzzese G, Bonuccelli U.

Mov Disord. 2013 Sep;28(10):1391-7. doi: 10.1002/mds.25585. Epub 2013 Jul 8.

PMID:
23836370
[PubMed - indexed for MEDLINE]
10.

Parkinson disease: Long-term levodopa exposure may increase risk of neuropathy in patients with PD.

Wood H.

Nat Rev Neurol. 2013 Sep;9(9):486. doi: 10.1038/nrneurol.2013.155. Epub 2013 Aug 6. No abstract available.

PMID:
23917846
[PubMed - indexed for MEDLINE]
11.

Neuroprotection for Parkinson's disease.

Koller WC.

Ann Neurol. 1998 Sep;44(3 Suppl 1):S155-9. Review.

PMID:
9749588
[PubMed - indexed for MEDLINE]
12.

The initial treatment of Parkinson's disease.

Factor SA.

Mov Disord. 2000 Mar;15(2):360-1. No abstract available.

PMID:
10752599
[PubMed - indexed for MEDLINE]
13.

Neuropathy as a potential complication of levodopa use in Parkinson's disease: a pharmacological and pharmacovigilance point of view.

Montastruc JL, Danton AC, Durrieu G, Lacroix I, Olivier P, Sommet A, Senard JM; French Association of Regional, PharmacoVigilance Centres.

Mov Disord. 2010 Apr 15;25(5):660-1. doi: 10.1002/mds.22878. No abstract available.

PMID:
20213824
[PubMed - indexed for MEDLINE]
14.

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Other studies have not shown increased mortality.

Mäki-Ikola O, Kilkku O, Heinonen E.

BMJ. 1996 Mar 16;312(7032):702; author reply 704-5. No abstract available.

PMID:
8597744
[PubMed - indexed for MEDLINE]
Free PMC Article
15.

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. Patients taking selegeline may have received more levodopa than necessary.

Olanow CW, Godbold JH, Koller W.

BMJ. 1996 Mar 16;312(7032):702-3; author reply 704-5. No abstract available.

PMID:
8597746
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Levodopa-induced hyperhomocysteinaemia in Parkinson's disease.

Yasui K, Nakaso K, Kowa H, Takeshima T, Nakashima K.

Acta Neurol Scand. 2003 Jul;108(1):66-7. No abstract available.

PMID:
12807397
[PubMed - indexed for MEDLINE]
17.

Ropinirole as compared with levodopa in Parkinson's disease.

Weiner WJ, Factor SA.

N Engl J Med. 2000 Sep 21;343(12):885. No abstract available.

PMID:
11001687
[PubMed - indexed for MEDLINE]
18.

Levodopa, methylmalonic acid, and neuropathy in idiopathic Parkinson disease.

Toth C, Breithaupt K, Ge S, Duan Y, Terris JM, Thiessen A, Wiebe S, Zochodne DW, Suchowersky O.

Ann Neurol. 2010 Jul;68(1):28-36. doi: 10.1002/ana.22021.

PMID:
20582991
[PubMed - indexed for MEDLINE]
19.

Ropinirole as compared with levodopa in Parkinson's disease.

Frucht S.

N Engl J Med. 2000 Sep 21;343(12):885. No abstract available.

PMID:
11001686
[PubMed - indexed for MEDLINE]
20.

Ropinirole as compared with levodopa in Parkinson's disease.

Yamamoto T.

N Engl J Med. 2000 Sep 21;343(12):884; author reply 885. No abstract available.

PMID:
11001685
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk